Compounds > debrisoquin

debrisoquin and omeprazole

debrisoquin has been researched along with omeprazole in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (42.86)	18.2507
2000's	3 (42.86)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Caraco, Y; Tateishi, T; Wood, AJ	1
Caraco, Y; Wilkinson, GR; Wood, AJ	1
Bertilsson, L; Böttiger, Y; Brynne, N; Hallén, B	1
Andersson, K; Bertilsson, L; Carrillo, JA; Christensen, M; Dahl, ML; Mihara, K; Ramos, SI; Tybring, G; Yasui-Furokori, N	1
Booker, BM; Brazeau, D; Cloen, D; Frerichs, V; Frye, RF; Haas, CE; Kufel, T; Zaranek, C	1

Trials

5 trial(s) available for debrisoquin and omeprazole

Article	Year
Interethnic difference in omeprazole's inhibition of diazepam metabolism. Clinical pharmacology and therapeutics, 1995, Volume: 58, Issue:1 Topics: Adult; Asian People; China; Cross-Over Studies; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Debrisoquin; Diazepam; Double-Blind Method; Drug Interactions; Ethnicity; Humans; Male; Mephenytoin; Nordazepam; Omeprazole; Tennessee; White People	1995
Differences between white subjects and Chinese subjects in the in vivo inhibition of cytochrome P450s 2C19, 2D6, and 3A by omeprazole. Clinical pharmacology and therapeutics, 1996, Volume: 60, Issue:4 Topics: Adult; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Asian People; China; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dapsone; Debrisoquin; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Humans; Male; Mephenytoin; Mixed Function Oxygenases; Omeprazole; White People	1996
Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole. British journal of clinical pharmacology, 1999, Volume: 47, Issue:2 Topics: Adult; Anti-Ulcer Agents; Antihypertensive Agents; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Cresols; Cross-Over Studies; Cytochromes; Debrisoquin; Drug Interactions; Humans; Male; Muscarinic Antagonists; Omeprazole; Phenylpropanolamine; Polymorphism, Genetic; Tolterodine Tartrate; Urinary Bladder Diseases	1999
Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19). Clinical pharmacology and therapeutics, 2002, Volume: 71, Issue:3 Topics: Adrenergic Agents; Adult; Area Under Curve; Caffeine; Central Nervous System Stimulants; Cytochrome P-450 CYP1A2 Inhibitors; Debrisoquin; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Fluvoxamine; Humans; Male; Middle Aged; Omeprazole; Selective Serotonin Reuptake Inhibitors	2002
Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction. European journal of clinical pharmacology, 2005, Volume: 61, Issue:8 Topics: Adult; Caffeine; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Gene Expression Regulation, Enzymologic; Humans; Leukocytes, Mononuclear; Male; Midazolam; Omeprazole; Rifampin; RNA, Messenger	2005

Other Studies

2 other study(ies) available for debrisoquin and omeprazole

Article	Year
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010